fda advisory_committee_meeting
saveAstraZeneca Plc — capivasertib (FDA Advisory Committee Meeting)
community read0 votes
Therapy area: Oncology. Indication: Hormone-Sensitive Prostate Cancer
Therapy area: Oncology. Indication: Hormone-Sensitive Prostate Cancer